Global Dolutegravir Market Growth 2025-2031

December 2025 | 98 pages | ID: G45EF24C418EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Dolutegravir market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Dolutegravir is an antiviral medication used, together with other medication, to treat HIV/AIDS. It may also be used, as part of post exposure prophylaxis, to prevent HIV infection following potential exposure. It is a type of integrase inhibitor, which blocks the action of the integrase enzyme, which is involved in viral replication. This helps to reduce the amount of virus in the body and may help to improve symptoms. Dolutegravir is taken as a tablet once daily, with or without food.

The future market trends of Dolutegravir are expected to be influenced by the following factors:The increasing incidence of HIV/AIDS, rising demand for better treatment options, and the growing number of approvals for Dolutegravir.The introduction of new drugs and formulations that may offer better efficacy and safety than Dolutegravir, such as long-acting injectable formulations, dual therapies, and novel integrase inhibitors.The expansion of the market in emerging regions, such as Asia-Pacific and Latin America, where Dolutegravir has been approved or is under review by regulatory authorities.The impact of the COVID-19 pandemic, which may increase the risk of HIV infection and affect the access and adherence to Dolutegravir treatment.

LP Information, Inc. (LPI) ' newest research report, the “Dolutegravir Industry Forecast” looks at past sales and reviews total world Dolutegravir sales in 2024, providing a comprehensive analysis by region and market sector of projected Dolutegravir sales for 2025 through 2031. With Dolutegravir sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dolutegravir industry.

This Insight Report provides a comprehensive analysis of the global Dolutegravir landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dolutegravir portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dolutegravir market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dolutegravir and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dolutegravir.

This report presents a comprehensive overview, market shares, and growth opportunities of Dolutegravir market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 10mg Tablets
  • 50mg Tablets
Segmentation by Application:
  • Prevent HIV Infection Following Potential Exposure
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • ViiV Healthcare (GSK)
  • Shanghai Desano Pharmaceuticals
  • Mylan
  • Aurobindo Pharma
  • LAURUS Labs
  • Adcock Ingram Limited
Key Questions Addressed in this Report

What is the 10-year outlook for the global Dolutegravir market?

What factors are driving Dolutegravir market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Dolutegravir market opportunities vary by end market size?

How does Dolutegravir break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dolutegravir Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Dolutegravir by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Dolutegravir by Country/Region, 2020, 2024 & 2031
2.2 Dolutegravir Segment by Type
  2.2.1 10mg Tablets
  2.2.2 50mg Tablets
2.3 Dolutegravir Sales by Type
  2.3.1 Global Dolutegravir Sales Market Share by Type (2020-2025)
  2.3.2 Global Dolutegravir Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Dolutegravir Sale Price by Type (2020-2025)
2.4 Dolutegravir Segment by Application
  2.4.1 Prevent HIV Infection Following Potential Exposure
  2.4.2 Others
2.5 Dolutegravir Sales by Application
  2.5.1 Global Dolutegravir Sale Market Share by Application (2020-2025)
  2.5.2 Global Dolutegravir Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Dolutegravir Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Dolutegravir Breakdown Data by Company
  3.1.1 Global Dolutegravir Annual Sales by Company (2020-2025)
  3.1.2 Global Dolutegravir Sales Market Share by Company (2020-2025)
3.2 Global Dolutegravir Annual Revenue by Company (2020-2025)
  3.2.1 Global Dolutegravir Revenue by Company (2020-2025)
  3.2.2 Global Dolutegravir Revenue Market Share by Company (2020-2025)
3.3 Global Dolutegravir Sale Price by Company
3.4 Key Manufacturers Dolutegravir Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Dolutegravir Product Location Distribution
  3.4.2 Players Dolutegravir Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DOLUTEGRAVIR BY GEOGRAPHIC REGION

4.1 World Historic Dolutegravir Market Size by Geographic Region (2020-2025)
  4.1.1 Global Dolutegravir Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Dolutegravir Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Dolutegravir Market Size by Country/Region (2020-2025)
  4.2.1 Global Dolutegravir Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Dolutegravir Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dolutegravir Sales Growth
4.4 APAC Dolutegravir Sales Growth
4.5 Europe Dolutegravir Sales Growth
4.6 Middle East & Africa Dolutegravir Sales Growth

5 AMERICAS

5.1 Americas Dolutegravir Sales by Country
  5.1.1 Americas Dolutegravir Sales by Country (2020-2025)
  5.1.2 Americas Dolutegravir Revenue by Country (2020-2025)
5.2 Americas Dolutegravir Sales by Type (2020-2025)
5.3 Americas Dolutegravir Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dolutegravir Sales by Region
  6.1.1 APAC Dolutegravir Sales by Region (2020-2025)
  6.1.2 APAC Dolutegravir Revenue by Region (2020-2025)
6.2 APAC Dolutegravir Sales by Type (2020-2025)
6.3 APAC Dolutegravir Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Dolutegravir by Country
  7.1.1 Europe Dolutegravir Sales by Country (2020-2025)
  7.1.2 Europe Dolutegravir Revenue by Country (2020-2025)
7.2 Europe Dolutegravir Sales by Type (2020-2025)
7.3 Europe Dolutegravir Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dolutegravir by Country
  8.1.1 Middle East & Africa Dolutegravir Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Dolutegravir Revenue by Country (2020-2025)
8.2 Middle East & Africa Dolutegravir Sales by Type (2020-2025)
8.3 Middle East & Africa Dolutegravir Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dolutegravir
10.3 Manufacturing Process Analysis of Dolutegravir
10.4 Industry Chain Structure of Dolutegravir

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Dolutegravir Distributors
11.3 Dolutegravir Customer

12 WORLD FORECAST REVIEW FOR DOLUTEGRAVIR BY GEOGRAPHIC REGION

12.1 Global Dolutegravir Market Size Forecast by Region
  12.1.1 Global Dolutegravir Forecast by Region (2026-2031)
  12.1.2 Global Dolutegravir Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Dolutegravir Forecast by Type (2026-2031)
12.7 Global Dolutegravir Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 ViiV Healthcare (GSK)
  13.1.1 ViiV Healthcare (GSK) Company Information
  13.1.2 ViiV Healthcare (GSK) Dolutegravir Product Portfolios and Specifications
  13.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 ViiV Healthcare (GSK) Main Business Overview
  13.1.5 ViiV Healthcare (GSK) Latest Developments
13.2 Shanghai Desano Pharmaceuticals
  13.2.1 Shanghai Desano Pharmaceuticals Company Information
  13.2.2 Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolios and Specifications
  13.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Shanghai Desano Pharmaceuticals Main Business Overview
  13.2.5 Shanghai Desano Pharmaceuticals Latest Developments
13.3 Mylan
  13.3.1 Mylan Company Information
  13.3.2 Mylan Dolutegravir Product Portfolios and Specifications
  13.3.3 Mylan Dolutegravir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Mylan Main Business Overview
  13.3.5 Mylan Latest Developments
13.4 Aurobindo Pharma
  13.4.1 Aurobindo Pharma Company Information
  13.4.2 Aurobindo Pharma Dolutegravir Product Portfolios and Specifications
  13.4.3 Aurobindo Pharma Dolutegravir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Aurobindo Pharma Main Business Overview
  13.4.5 Aurobindo Pharma Latest Developments
13.5 LAURUS Labs
  13.5.1 LAURUS Labs Company Information
  13.5.2 LAURUS Labs Dolutegravir Product Portfolios and Specifications
  13.5.3 LAURUS Labs Dolutegravir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 LAURUS Labs Main Business Overview
  13.5.5 LAURUS Labs Latest Developments
13.6 Adcock Ingram Limited
  13.6.1 Adcock Ingram Limited Company Information
  13.6.2 Adcock Ingram Limited Dolutegravir Product Portfolios and Specifications
  13.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Adcock Ingram Limited Main Business Overview
  13.6.5 Adcock Ingram Limited Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Dolutegravir Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Dolutegravir Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 10mgTablets
Table 4. Major Players of 50mgTablets
Table 5. Global Dolutegravir Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Dolutegravir Sales Market Share by Type (2020-2025)
Table 7. Global Dolutegravir Revenue by Type (2020-2025) & ($ million)
Table 8. Global Dolutegravir Revenue Market Share by Type (2020-2025)
Table 9. Global Dolutegravir Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Dolutegravir Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Dolutegravir Sale Market Share by Application (2020-2025)
Table 12. Global Dolutegravir Revenue by Application (2020-2025) & ($ million)
Table 13. Global Dolutegravir Revenue Market Share by Application (2020-2025)
Table 14. Global Dolutegravir Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Dolutegravir Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Dolutegravir Sales Market Share by Company (2020-2025)
Table 17. Global Dolutegravir Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Dolutegravir Revenue Market Share by Company (2020-2025)
Table 19. Global Dolutegravir Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Dolutegravir Producing Area Distribution and Sales Area
Table 21. Players Dolutegravir Products Offered
Table 22. Dolutegravir Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Dolutegravir Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Dolutegravir Sales Market Share Geographic Region (2020-2025)
Table 27. Global Dolutegravir Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Dolutegravir Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Dolutegravir Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Dolutegravir Sales Market Share by Country/Region (2020-2025)
Table 31. Global Dolutegravir Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Dolutegravir Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Dolutegravir Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Dolutegravir Sales Market Share by Country (2020-2025)
Table 35. Americas Dolutegravir Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Dolutegravir Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Dolutegravir Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Dolutegravir Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Dolutegravir Sales Market Share by Region (2020-2025)
Table 40. APAC Dolutegravir Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Dolutegravir Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Dolutegravir Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Dolutegravir Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Dolutegravir Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Dolutegravir Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Dolutegravir Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Dolutegravir Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Dolutegravir Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Dolutegravir Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Dolutegravir Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Dolutegravir
Table 52. Key Market Challenges & Risks of Dolutegravir
Table 53. Key Industry Trends of Dolutegravir
Table 54. Dolutegravir Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Dolutegravir Distributors List
Table 57. Dolutegravir Customer List
Table 58. Global Dolutegravir Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Dolutegravir Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Dolutegravir Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Dolutegravir Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Dolutegravir Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Dolutegravir Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Dolutegravir Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Dolutegravir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Dolutegravir Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Dolutegravir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Dolutegravir Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Dolutegravir Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Dolutegravir Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Dolutegravir Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. ViiV Healthcare (GSK) Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 73. ViiV Healthcare (GSK) Dolutegravir Product Portfolios and Specifications
Table 74. ViiV Healthcare (GSK) Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. ViiV Healthcare (GSK) Main Business
Table 76. ViiV Healthcare (GSK) Latest Developments
Table 77. Shanghai Desano Pharmaceuticals Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 78. Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolios and Specifications
Table 79. Shanghai Desano Pharmaceuticals Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Shanghai Desano Pharmaceuticals Main Business
Table 81. Shanghai Desano Pharmaceuticals Latest Developments
Table 82. Mylan Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 83. Mylan Dolutegravir Product Portfolios and Specifications
Table 84. Mylan Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. Mylan Main Business
Table 86. Mylan Latest Developments
Table 87. Aurobindo Pharma Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 88. Aurobindo Pharma Dolutegravir Product Portfolios and Specifications
Table 89. Aurobindo Pharma Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Aurobindo Pharma Main Business
Table 91. Aurobindo Pharma Latest Developments
Table 92. LAURUS Labs Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 93. LAURUS Labs Dolutegravir Product Portfolios and Specifications
Table 94. LAURUS Labs Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. LAURUS Labs Main Business
Table 96. LAURUS Labs Latest Developments
Table 97. Adcock Ingram Limited Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 98. Adcock Ingram Limited Dolutegravir Product Portfolios and Specifications
Table 99. Adcock Ingram Limited Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Adcock Ingram Limited Main Business
Table 101. Adcock Ingram Limited Latest Developments

LIST OF FIGURES

Figure 1. Picture of Dolutegravir
Figure 2. Dolutegravir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dolutegravir Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Dolutegravir Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Dolutegravir Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Dolutegravir Sales Market Share by Country/Region (2024)
Figure 10. Dolutegravir Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 10mgTablets
Figure 12. Product Picture of 50mgTablets
Figure 13. Global Dolutegravir Sales Market Share by Type in 2025
Figure 14. Global Dolutegravir Revenue Market Share by Type (2020-2025)
Figure 15. Dolutegravir Consumed in Prevent HIV Infection Following Potential Exposure
Figure 16. Global Dolutegravir Market: Prevent HIV Infection Following Potential Exposure (2020-2025) & (K Pcs)
Figure 17. Dolutegravir Consumed in Others
Figure 18. Global Dolutegravir Market: Others (2020-2025) & (K Pcs)
Figure 19. Global Dolutegravir Sale Market Share by Application (2024)
Figure 20. Global Dolutegravir Revenue Market Share by Application in 2025
Figure 21. Dolutegravir Sales by Company in 2025 (K Pcs)
Figure 22. Global Dolutegravir Sales Market Share by Company in 2025
Figure 23. Dolutegravir Revenue by Company in 2025 ($ millions)
Figure 24. Global Dolutegravir Revenue Market Share by Company in 2025
Figure 25. Global Dolutegravir Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Dolutegravir Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Dolutegravir Sales 2020-2025 (K Pcs)
Figure 28. Americas Dolutegravir Revenue 2020-2025 ($ millions)
Figure 29. APAC Dolutegravir Sales 2020-2025 (K Pcs)
Figure 30. APAC Dolutegravir Revenue 2020-2025 ($ millions)
Figure 31. Europe Dolutegravir Sales 2020-2025 (K Pcs)
Figure 32. Europe Dolutegravir Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Dolutegravir Sales 2020-2025 (K Pcs)
Figure 34. Middle East & Africa Dolutegravir Revenue 2020-2025 ($ millions)
Figure 35. Americas Dolutegravir Sales Market Share by Country in 2025
Figure 36. Americas Dolutegravir Revenue Market Share by Country (2020-2025)
Figure 37. Americas Dolutegravir Sales Market Share by Type (2020-2025)
Figure 38. Americas Dolutegravir Sales Market Share by Application (2020-2025)
Figure 39. United States Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Dolutegravir Sales Market Share by Region in 2025
Figure 44. APAC Dolutegravir Revenue Market Share by Region (2020-2025)
Figure 45. APAC Dolutegravir Sales Market Share by Type (2020-2025)
Figure 46. APAC Dolutegravir Sales Market Share by Application (2020-2025)
Figure 47. China Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 51. India Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Dolutegravir Sales Market Share by Country in 2025
Figure 55. Europe Dolutegravir Revenue Market Share by Country (2020-2025)
Figure 56. Europe Dolutegravir Sales Market Share by Type (2020-2025)
Figure 57. Europe Dolutegravir Sales Market Share by Application (2020-2025)
Figure 58. Germany Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 59. France Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Dolutegravir Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Dolutegravir Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Dolutegravir Sales Market Share by Application (2020-2025)
Figure 66. Egypt Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Dolutegravir Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Dolutegravir in 2025
Figure 72. Manufacturing Process Analysis of Dolutegravir
Figure 73. Industry Chain Structure of Dolutegravir
Figure 74. Channels of Distribution
Figure 75. Global Dolutegravir Sales Market Forecast by Region (2026-2031)
Figure 76. Global Dolutegravir Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Dolutegravir Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Dolutegravir Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Dolutegravir Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Dolutegravir Revenue Market Share Forecast by Application (2026-2031)


More Publications

Global Dolutegravir Sodium Market Growth 2025-2031 US$ 3,660.00 December 2025 101 pages